Esophageal aspergillosis after bone marrow transplant.
The prolonged immune suppression associated with bone marrow transplants predisposes to fungal infections including Aspergillus. Disseminated aspergillosis occurs in up to 60% of patients with invasive pulmonary aspergillosis; sites of involvement include the brain, gastrointestinal tract, kidney, liver, thyroid, heart, and spleen. There is only one report of isolated esophageal aspergillosis. A recent acute myelogenous leukemia patient had isolated esophageal aspergillosis after bone marrow transplantation which was successfully treated with amphotericin B.
Choi
J H
JH
Bone Marrow Transplantation Center, St Mary's Hospital, Catholic University Medical College, Seoul, Korea.
Yoo
J H
JH
Chung
I J
IJ
Kim
D W
DW
Han
C W
CW
Shin
W S
WS
Min
W S
WS
Park
C W
CW
Kim
C C
CC
Kim
D J
DJ
D000328:Adult; D001228:Aspergillosis / Q000209:etiology*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004935:Esophageal Diseases / Q000209:etiology*; D006801:Humans; D008297:Male